2006
DOI: 10.1590/s0066-782x2006001700001
|View full text |Cite
|
Sign up to set email alerts
|

Ativação plaquetária nas formas distintas da doença arterial coronariana

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Thus, TXA2 is coresponsible, together with ADP, for the posterior growth of the hemostatic plug. 36 The observed inhibitory effect can be explained if it is found that coffee is able to inhibit platelets, because if this occurs, the factors necessary for the production of TXA2 or its inactive form, TXB2, will not be released from the platelets. Regarding the studies that verify the lack of effect of coffee on thromboxanes, they may present a bad classification bias and it should be noted that the same occurred in the years 1985 and 1989, being, therefore, older in relation to the study that observes the inhibition of the formation of this regulator.…”
Section: Coffee and Prostanoidsmentioning
confidence: 99%
See 2 more Smart Citations
“…Thus, TXA2 is coresponsible, together with ADP, for the posterior growth of the hemostatic plug. 36 The observed inhibitory effect can be explained if it is found that coffee is able to inhibit platelets, because if this occurs, the factors necessary for the production of TXA2 or its inactive form, TXB2, will not be released from the platelets. Regarding the studies that verify the lack of effect of coffee on thromboxanes, they may present a bad classification bias and it should be noted that the same occurred in the years 1985 and 1989, being, therefore, older in relation to the study that observes the inhibition of the formation of this regulator.…”
Section: Coffee and Prostanoidsmentioning
confidence: 99%
“…35 Prostanoids are eicosoids, a group to which prostacyclins, prostaglandins, and thromboxanes belong. Among these, prostacyclins, 36 prostaglandin I2 (PGI2), 37 and cyclic 3'5'-adenosine monophosphate (cyclic AMP or cAMP) are regulators that have antiplatelet action. On the other hand, thromboxane A2 (TXA2) and thromboxane B2 (TXB2) have aggregating action, 36 as well as the inhibitor of plasminogen activator type 1 (PAI-1) that can promote the permanence of the fibrin clot inhibiting fibrinolysis.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation